India's Covid-19 vaccines effective against new variants
Interim results of the ongoing clinical trial indicate that the indigenous Covid-19 vaccines would be effective against the mutated virus strains reported from the United Kingdom, South Africa and Brazil, said the Indian Council of Medical Research (ICMR) on Thursday.
Bhargava said that the third clinical trial of Covaxin BB152 had been completed as all the 25,800 volunteers involved in the exercise had been administered both doses.
Bhargava pointed out that India was the fifth country in the world to isolate the Covid-19 virus as part of the efforts to develop a vaccine for the pandemic.
New variants in India
The ICMR had on Tuesday announced that the South African variant of coronavirus circulating in more than 44 countries has entered India with four people having been detected with the strain.
"The strain has multiple mutations, including in the receptor-binding domain of the spike protein allowing the virus to easily enter the lung cells of the human body. The majority of the cases in South Africa are due to the variant strain and it has spread to 44 countries," Bhargava had said.